HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Links / Indication-level Pricing: Payer Insights

Indication-level Pricing: Payer Insights

Advocates argue that indication-level pricing can bring new products on stream and results in wider patient access to new therapies. That’s a good thing, right? Maybe, but for indication-level pricing to work payers would have to overcome a range of practical and costly administrative, data collection and regulatory obstacles. There is also the perennial payers’ suspicion that profit underlies pharma’s enthusiasm. Pharma wants optimum price, payers want value and patients need access–but is indication-level pricing a model that is ever likely to deliver at pace and scale, and what can pharma do now to progress the argument for indication-level pricing with payers?

Understanding in detail what payers see as the main issues and areas of objection is critical. That is why, in Indication-level Pricing: Payer insights, we interviewed experienced payers from the US and Europe to help you evaluate where–and how–pharma can act.

Payers explore indication-level pricing challenges

  • What are the problems caused by having a single price for a multi-indication drug?
  • Different brand names or delivery/dosage forms? Discounts by indication? Outcomes-based payments? What models find traction with payers and what are their objections?
  • How should value be determined for indication-level pricing?
  • What are the data challenges for implementing indication-level pricing and how can they be overcome?
  • What are the contractual and financial flows challenges for implementing indication-level pricing?
  • How could misuse of indication-level pricing be overcome?

Click here for more information about this report.



You might also be interested in:

  • Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
  • HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership 04/10/2020
  • New Book Release by RJG Arnold: Pharmacoeconomics: From Theory… 01/14/2021
  • Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE… 06/16/2020
  • AHRQ’s Registries User Guide Gets A New Edition 09/24/2020
  • Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
  • How HEOR Professionals Can Be Force Multipliers in the Fight… 10/06/2020

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Whitepaper: The Role of Centralized Care Management in Value-based Care
  • 2017 In-Depth Outlook on Oncology Report
  • Value-Based Healthcare: Making it Happen
  • Value-Based Contracting for Biopharmaceuticals Moves Forward
  • ICER Releases White Paper on Gene Therapy

Syndicated Reports

  • HTA in Europe: Key Success Factors for Positive HTA Recommendations
  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
  • Biosimilars: US Payer Perspectives
  • KAM Metrics: Driving Efficiency, Measuring Success
HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute